Skip to main content

Advertisement

Log in

Successful Management of Congenital Chylous Ascites in a Premature Infant Using Somatostatin Analogue

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Congenital chylous ascites (CCA) is a rare disease defined as the accumulation of chylomicron-rich lymphatic fluid within the peritoneal cavity, resulting from maldevelopment of the intra-abdominal lymphatic system. Cases unresponsive to conservative treatment usually require surgical intervention. We report a case of CCA in a premature neonate, who was treated successfully with intravenous infusion of octreotide, a synthetic somatostatin analogue after failure to response to traditional supportive therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Browse NL, Wilson NM, Russo F, al-Hassan H, Allen DR. Aetiology and treatment of chylous ascites. Br J Surg. 1992;79:1145–50.

    Article  PubMed  CAS  Google Scholar 

  2. Ulíbarri JI, Sanz Y, Fuentes C, et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet. 1990;336:258.

    Article  PubMed  Google Scholar 

  3. Caty MG, Hilfiker ML, Azizkhan RG, Glick PL. Successful treatment of congenital chylous ascites with a somatostatin analogue. Pediatr Surg Int. 1996;11:396–7.

    Article  Google Scholar 

  4. te Pas AB, vd Ven K, Stokkel MP, Walther FJ. Intractable congenital chylous ascites. Acta Paediatr. 2004;93:1403–5.

    Article  Google Scholar 

  5. Mishra R, Kumar S. Octreotide in congenital chylous ascites an avoid requirement of total parenteral nutrition. Indian J Gastroenterol. 2007;26:299–300.

    PubMed  Google Scholar 

  6. Rasiah SV, Oei J, Lui K. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health. 2004;40:585–8.

    Article  PubMed  CAS  Google Scholar 

  7. Mohseni-Bod H, Macrae D, Slavik Z. Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med. 2004;5:356–7.

    Article  PubMed  Google Scholar 

  8. Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N. Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg. 2003;38:251–3.

    Article  PubMed  CAS  Google Scholar 

  9. Schiedermaier P, Brensing KA, Göke B, Schätzle T, Sauerbruch T. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers. Digestion. 1999;60:132–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuefang Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, Y., Zhuang, S., Li, Y. et al. Successful Management of Congenital Chylous Ascites in a Premature Infant Using Somatostatin Analogue. Indian J Pediatr 78, 345–347 (2011). https://doi.org/10.1007/s12098-010-0256-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-010-0256-1

Keywords

Navigation